Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects
Abstract This study compared the pharmacokinetic and glucodynamic profiles of biosimilar SAR341402 insulin aspart to Japan-approved insulin aspart (NovoRapid) in healthy Japanese males. In this single-center, randomized, double-blind, single-dose, two-period, crossover study, subjects received 0.3 U...
Enregistré dans:
Auteurs principaux: | Masanari Shiramoto, Tatsuya Yoshihara, Wolfgang Schmider, Hiroki Takagi, Irene Nowotny, Miyuki Kajiwara, Hideya Muto |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/91ffc0df4bcd43f98107227aa96b64ad |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males
par: Hui Liu, et autres
Publié: (2021) -
Author Correction: Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males
par: Hui Liu, et autres
Publié: (2021) -
Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
par: Hanne Haahr, et autres
Publié: (2020) -
Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
par: Jinhai Wang, et autres
Publié: (2021) -
The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
par: Andrzej Czyrski, et autres
Publié: (2021)